GI symptom
[용어속성] Term
Factors Associated With Severe Gastrointestinal Diagnoses in Children With SARS-CoV-2 Infection or Multisystem Inflammatory Syndrome
Research
[키워드] 95% CI
abdomen
abdominal pain
acute SARS-CoV-2 infection
adjusted
Admission
age
Appendicitis
center
Characteristics
characterized
children
children with COVID-19
Clinical course
Clinical outcome
cohort study
complications
conducted
Control
COVID-19
criteria
defined
diagnosed
Diagnosis
enrolled
Factor
finding
Frequency
Gastrointestinal
gastrointestinal involvement
GI symptom
help
hospital
Hospitalization
identify
ileal
Importance
IMPROVE
Infection
infection with SARS-CoV-2
Infectious diseases
Inflammatory
intensive care
Italian
Italy
large cohort
leukopenia
lymphopenia
management
manifestation
Manifestations
measure
median age
MIS-C
multicenter
multicenter cohort study
Nasopharyngeal swab
objective
Occurrence
Odds ratio
Older
outcome
outcomes
participant
Point
positive
Practitioner
presenting
prevention
primary care
radiological
Radiological Diagnosis
receiving
registry
Relevance
reported
Result
retrospective cohort study
risk
SARS-CoV-2
SARS-COV-2 infection
setting
Society
surgical
syndrome
was used
[DOI] 10.1001/jamanetworkopen.2021.39974 PMC 바로가기 [Article Type] Research
[DOI] 10.1001/jamanetworkopen.2021.39974 PMC 바로가기 [Article Type] Research
COVID-19 and gut immunomodulation
코로나19와 장 면역 조절
Review
[키워드] acute respiratory syndrome
Adaptive immune response
addition
angiotensin-converting enzyme-2
antibodies
association
calprotectin
changes in
clinically
Comorbidities
coronavirus
coronavirus disease
COVID-19
COVID-19 patient
COVID-19 patients
Cytokines
dependent on
direct infection
disease
disease severity
Dysbiosis
epithelial cell
expresse
Gastrointestinal
gastrointestinal symptoms
GI symptom
GI symptoms
GI Tract
Gut
gut microbiota
Health
heterogeneous
hypoxia
immune
immune activation
immune response
Immunity
immunoglobulin A
impairment
in vitro
in vivo
infect
infected individual
Infection
Innate
innate immune response
intestinal epithelium
observation
organ
organoids
outcome
Pathogenesis
Patient
positive
Pre-existing diseases
Probiotic
Proinflammatory cytokine
protease
Protein
reported
required
respiratory problems
respiratory symptom
Respiratory system
rhesus
SARS-CoV-2
serine 2
severe COVID-19 patient
severe respiratory illness
severity
Stool
supported
Symptom
symptomatic patient
the disease
therapeutic interventions
Therapeutics
transmembrane
Viral RNA
virus
[DOI] 10.3748/wjg.v27.i46.7925 PMC 바로가기 [Article Type] Review
[DOI] 10.3748/wjg.v27.i46.7925 PMC 바로가기 [Article Type] Review
Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms
Article
[키워드] acute phase
association
Biochemistry
Biomarkers
calprotectin
caused
cell damage
controls
COVID-19
COVID-19 case
COVID-19 disease
COVID-19 patient
diarrhea
disease severity
elevated
epithelial
fecal
Gastrointestinal symptom
GI symptom
Health care
healthy control
healthy individuals
immune system
immunology
inflammation marker
Inflammatory marker
Inflammatory response
investigated
manifestation
median
Medical research
not correlated
not significantly different
performed
progressed
progression
SARS-COV-2 infection
serum
subgroup
thought
triggered
uninfected
were measured
[DOI] 10.1038/s41598-021-01231-4 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41598-021-01231-4 PMC 바로가기 [Article Type] Article
931. Epidemiology and Clinical Outcomes of SARS-CoV-2 Infection Among Pediatric Solid Organ Transplant Recipients: A Single-Center Case Experience
Poster Abstracts
[키워드] Admission
Albireo
children
clinical
co-morbidity
Community
Confirmed COVID-19 infection
consultant
cough
deaths
demographic
disease
disease course
disease severity
Epidemiology
evaluate
experience
female
Fever
Fischer’s exact test
GI symptom
higher risk
Hispanic
Hospital admission
Hospital stay
Hospitalized
hospitalized patient
ICU
Inc
increased risk
Infection
intensive care
interquartile range
IQR
kidney
Kruskall-Wallis test
Laboratory
liver
majority
median age
Mild
moderate
moderate disease
morbidity
Multiorgan
outcome
overweight/obese
Patient
pediatric
positive pressure ventilation
recipient
recipients
required
respiratory
Result
retrospective review
risk
risk factor
SARS-CoV-2
SARS-COV-2 infection
Seven
severe disease
Solid
solid organ transplant
SOT
stratified
Transplant
Univariate analysis
were used
[DOI] 10.1093/ofid/ofab466.1126 PMC 바로가기 [Article Type] Poster Abstracts
[DOI] 10.1093/ofid/ofab466.1126 PMC 바로가기 [Article Type] Poster Abstracts
Gastrointestinal implications in COVID-19
Research Article
[키워드] accompanied
coronavirus
Coronavirus disease 2019
COVID-19
COVID-19 patient
COVID-19 patients
cross-sectional
evaluate
evaluated
Gastrointestinal
gastrointestinal symptoms
Gender
GI symptom
GI symptoms
group
homogeneous
implication
less
lymphopenia
manifestation
Mortality
nausea
Older
Patient
prevalent
respiratory symptom
respiratory symptoms
Result
RT-PCR
SARS-CoV-2
significantly
statistically significant
Symptoms
Treatment
typical respiratory symptom
vomiting
[DOI] 10.1186/s12879-021-06824-y PMC 바로가기 [Article Type] Research Article
[DOI] 10.1186/s12879-021-06824-y PMC 바로가기 [Article Type] Research Article
Gastrointestinal Bleeding, but Not Other Gastrointestinal Symptoms, Is Associated With Worse Outcomes in COVID-19 Patients
Medicine
[키워드] 95% CI
95% confidence interval
abdominal discomfort
abdominal pain
age
Analysis
association
bleeding
calculated
CIs
collected
composite endpoint
constipation
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 patient
COVID-19 patients
death
death in COVID-19
defined
demonstrated
diarrhea
evaluate
Gastrointestinal
gastrointestinal symptoms
GI symptom
GI symptoms
hospital
independent
intensive care
Logistic regression
Logistic regression analysis
mechanical ventilation
nausea
Other
outcome
outcomes
patients
performed
Prevalence
proportion
severe acute respiratory syndrome coronavirus 2
severe COVID-19
severity
Sex
significantly
significantly higher
Symptom
Symptoms
transfer
vomiting
Wuhan
[DOI] 10.3389/fmed.2021.759152 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.759152 PMC 바로가기 [Article Type] Medicine
Dynamics of the COVID-19 Clinical Findings and the Serologic Response
Microbiology
[키워드] ABO blood group antigen
affecting
age
anti-SARS-CoV-2
anti-SARS-CoV-2 antibody
anti-SARS-CoV-2 IgM
antibody
antibody sustain
antibody test result
Asymptomatic
baseline
BMI
body mass index
Characteristics
Chest computed tomography
cirrhosis
clinical
Clinical features
clinical presentation
COVID-19
declined
declining
diarrhea
Dynamics
Factor
female
finding
Follow-up
gastrointestinal symptoms
GI symptom
IgG
IgG level
IgM
IgM and IgG
IgM/IgG
lung involvement
male
persistent disease
positive
respiratory symptoms
response
selected
serologic
Serologic response
subject
Symptom
symptomatic
Symptoms
the mean
[DOI] 10.3389/fmicb.2021.743048 PMC 바로가기 [Article Type] Microbiology
[DOI] 10.3389/fmicb.2021.743048 PMC 바로가기 [Article Type] Microbiology
Gastrointestinal Manifestation of COVID-19 in Hospitalized Patients
Internal Medicine
[키워드] analyzed
anorexia
Care
collected data
conducted
COVID 19
COVID-1
COVID-19
COVID-19 patient
COVID-19 patients
demographics
diarrhea
enrolled
Frequency
Gastrointestinal
gastrointestinal symptoms
GI symptom
GI symptoms
hospital
IBM
indicate
Infection
initial
less
manifestation
nausea
nausea/vomiting
pandemic
participant
Patient
patients hospitalized
presenting
Prevalence
questionnaire
reported symptoms
sars-cov-2 (severe acute respiratory syndrome coronavirus -2)
Science
SPSS
stages
Statistical Package
Symptom
these symptoms
vomiting
with COVID-19
[DOI] 10.7759/cureus.18024 PMC 바로가기 [Article Type] Internal Medicine
[DOI] 10.7759/cureus.18024 PMC 바로가기 [Article Type] Internal Medicine
What GI Physicians Need to Know During COVID-19 Pandemic
COVID-19 팬데믹 동안 소화기 의사가 알아야 할 사항
Review
[키워드] abnormality
ACE-2 receptor
anorexia
appear
caused
cell line
clearance
confounding factor
COVID-19
detected in stool
diarrhea
elevated
enzyme
Evidence
General population
GI symptom
GI symptoms
GI Tract
host cells
hypoxia
infection rate
infection rates
involved
liver
Liver disease
liver enzyme
liver enzymes
Liver manifestations: GI symptoms
Loss of Smell
management
medications
Mild
morbidity and mortality
Mortality
nausea
Patient
patients
patients with COVID-19
pharyngeal
physician
proportion
recommendation
Respiratory illness
RNA
SARS-CoV-2
Sepsis
severe disease
Severity of disease
Stool
Transmission
Viral RNA
virus
vomiting
worldwide pandemic
[DOI] 10.1007/s10620-020-06625-4 PMC 바로가기 [Article Type] Review
[DOI] 10.1007/s10620-020-06625-4 PMC 바로가기 [Article Type] Review